Acquisition Of The Pharmaceutical Specialty Halaven 0.44 Mg/Ml Injectable Solution 1 Vial Of 2 Ml (Erivulina), Destined For The Pharmacy Service Of The U. Ramón Y Cajal Hospital

HOSPITAL UNIVERSITARIO RAMON Y CAJAL Spain has Released a tender for Acquisition Of The Pharmaceutical Specialty Halaven 0.44 Mg/Ml Injectable Solution 1 Vial Of 2 Ml (Erivulina), Destined For The Pharmacy Service Of The U. Ramón Y Cajal Hospital in Pharmaceuticals. The tender was released on Feb 06, 2025.

Country - Spain

Summary - Acquisition Of The Pharmaceutical Specialty Halaven 0.44 Mg/Ml Injectable Solution 1 Vial Of 2 Ml (Erivulina), Destined For The Pharmacy Service Of The U. Ramón Y Cajal Hospital

Deadline - login to view

MT reference number - 102835906

Product classification - Antineoplastic agents

Organization Details:

  Address - Spain

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 102835906

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: Acquisition of the pharmaceutical specialty HALAVEN 0.44 mg/ml injectable solution 1 vial of 2 ml (Erivulina), destined for the Pharmacy Service of the U. Ramón y Cajal Hospitallocal title:: Adquisición de la especialidad farmacéutica HALAVEN 0,44 mg/ml solución inyectable 1 vial de 2 ml ( Erivulina), con destino al Servicio de Farmacia del Hospital U. Ramón y CajalContract Type: : Supplylocal description: : Adquisición de la especialidad farmacéutica HALAVEN 0,44 mg/ml solución inyectable 1 vial de 2 ml ( Erivulina), con destino al Servicio de Farmacia del Hospital U. Ramón y Cajal

Mt Ref Id - 102835906

Deadline - Feb 21, 2025

Share

Similar Tenders :